Scott Fleischer, MD
Geriatric Psychiatry · Fort Washington, PANPI 1316050693
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. Neuronetics, Inc. accounts for 68.9% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $1,918 and has fallen 87.0% since, to $249 in 2025. Among geriatric psychiatry clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 55 payments — averaging $51.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$2K
- AbbVie$146
- E.r. Squibb & Sons, L.L.C.$143
- Teva Pharmaceuticals USA, Inc.$81
- Lundbeck LLC$71
- Axsome Therapeutics, Inc.$50
- plus $393 from 13 others
What the payments were for
- Travel & lodging$1,21043%
- Food & beverage$1,59756%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 14 | $1,955 |
| AbbVie(2 entities) | 7 | $146 |
| E.r. Squibb & Sons, L.L.C. | 4 | $143 |
| Teva Pharmaceuticals USA, Inc. | 3 | $81 |
| Lundbeck LLC | 3 | $71 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Johnson & Johnson | 3 | $48 |
| Shire North American Group Inc | 3 | $44 |
| Sunovion Pharmaceuticals Inc. | 3 | $43 |
| Avanir Pharmaceuticals, Inc. | 2 | $42 |
| Biogen | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Livanova USA, Inc. | 1 | $22 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Bausch Health US, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,839 in reported general payments places this provider in the 90th percentile of 31 geriatric psychiatry providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 11 | $152,743 |
| VraylarCariprazine Hcl | 17 | $34,381 |
| LexaproEscitalopram Oxalate | 13 | $15,542 |
| Clozapine | 32 | $2,040 |
| Duloxetine Hcl | 139 | $2,015 |
| Aripiprazole | 42 | $1,610 |
| Lorazepam | 115 | $1,147 |
| Quetiapine Fumarate | 82 | $996 |
| Escitalopram Oxalate | 57 | $743 |
| Gabapentin | 61 | $696 |
| Clonazepam | 82 | $636 |
| Divalproex Sodium | 39 | $623 |
| Lamotrigine | 80 | $619 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 35 | $573 |
| Trazodone Hcl | 75 | $568 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $81 | $152,74311 claims |
| AbbVieVraylar, Lexapro | $146 | $49,92330 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 31 geriatric psychiatry providers in Pennsylvania.
Other geriatric psychiatry in Fort Washington
- Yong ShinPottstown$30K
- Jordan KarpPittsburgh$19K
- Rakesh SharmaKingston$3K
- David LiskovWilkes Barre$2K
- Marian GeorgievReading$2K
- Marie Anne GebaraPittsburgh$2K
- Anastasia SamarasPittsburgh$1K
- Babar ChoudhryPottsville$644
- Patalam SriharshaHazleton$511
- Edward GoebelBala Cynwyd$270
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.